000008361 001__ 8361
000008361 005__ 20240304155639.0
000008361 0247_ $$2DOI$$a10.6083/s7526d22m
000008361 037__ $$aIR
000008361 041__ $$aeng
000008361 245__ $$aA Community-based Assessment of Skin Care, Allergies and Eczema (CASCADE)
000008361 260__ $$bOregon Health and Science University
000008361 269__ $$a2020
000008361 336__ $$aAbstract
000008361 520__ $$aAtopic dermatitis (AD) is a chronic inflammatory skin disorder that affects approximately 13% of children in the United States. Typically, it develops in those less than 2 years old, resulting in a lifelong condition that is often connected to other disorders such as allergies and asthma, degrading the individual's quality of life. Skin barrier dysfunction allows for these disorders to develop, therefore targeting the skin's barrier potentially prevents disease.
000008361 540__ $$fCC BY
000008361 542__ $$fIn copyright - joint owners
000008361 650__ $$aEczema$$018207
000008361 650__ $$aDermatitis, Atopic$$017627
000008361 650__ $$aEmollients$$018359
000008361 650__ $$aAllergy and Immunology$$014456
000008361 6531_ $$aallergies
000008361 6531_ $$apediatric dermatology
000008361 6531_ $$abarrier dysfunction
000008361 692__ $$aOregon Rural Practice-based Research Network$$041499
000008361 7001_ $$aYoung, Amy$$uPortland State University$$041357
000008361 7001_ $$aEichner, Brian
000008361 711__ $$aResearch Week$$uOregon Health and Science University$$d2020
000008361 8564_ $$92c26ce69-ac1c-4e8c-bbe1-42dd1e45eec4$$s45068$$uhttps://digitalcollections.ohsu.edu/record/8361/files/ResearchWeek.2020.Young.Amy.pdf
000008361 905__ $$a/rest/prod/s7/52/6d/22/s7526d22m
000008361 980__ $$aResearch Week